Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months

J Travel Med. 2021 Dec 29;28(8):taab173. doi: 10.1093/jtm/taab173.

¹ Pineta Grande Hospital, Castel Volturno (Caserta), Italy.
² Center for Public Health Research, University of Milan-Bicocca, Monza, Italy.
³ Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
⁴ Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy.
⁵ Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
⁶ IRCCS MultiMedica, Sesto San Giovanni (Milan), Italy.

No abstract available

Keywords: Pfizer COVID-19 vaccine; S-RBD-specific; SARS-CoV-2; decreasing immunity; immunoglobulins; neutralizing antibodies; seroconversion.

MeSH terms